Bio Pharma Dive
JANUARY 20, 2023
The drugmaker had sought an accelerated approval based on promising data from a small mid-stage trial. Results from a larger study are due in the second quarter
Pharmaceutical Technology
JANUARY 20, 2023
Pharmaceutical supply chains are extremely vulnerable to the effects of climate change and face many challenges from sourcing to distribution.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 20, 2023
Analysts argue the FDA’s choice to decline accelerated approval for donanemab, while surprising, is not the main factor that will determine whether it eventually becomes a commercial success
Pharmaceutical Technology
JANUARY 20, 2023
This week, at the World Economic Forum Annual Meeting, Moderna CEO Stéphane Bancel, said the company plans to build on its exponential growth through the pandemic by expanding its operations globally over the next few years.
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Bio Pharma Dive
JANUARY 20, 2023
The regulator’s decision ends a seven-month study pause that followed a report of one participant experiencing mild symptoms of peripheral neuropathy
Pharmaceutical Technology
JANUARY 20, 2023
The demand for mAbs is increasing as they offer patients targeted treatments for a wide range of serious health conditions and diseases.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
JANUARY 20, 2023
BeiGene has received marketing authorisations for Brukinsa (zanubrutinib) in Great Britain from the Medicines and Healthcare products Regulatory Agency (MHRA) to treat chronic lymphocytic leukemia (CLL) and marginal zone lymphoma (MZL).
Pharma Times
JANUARY 20, 2023
The NICE recommendation followed data from clinical trials and real-world evidence
Pharmaceutical Technology
JANUARY 20, 2023
A genome-wide association study (GWAS) published in the Journal of Clinical Oncology has identified a potential association between a genetic variant and anthracycline-related cardiomyopathy in childhood cancer survivors.
Fierce Pharma
JANUARY 20, 2023
Ipsen's Onivyde proves its worth in aggressive pancreatic cancer zbecker Fri, 01/20/2023 - 10:48
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Pharma Times
JANUARY 20, 2023
Therapy involves patients living with relapsed or refractory multiple myeloma
Fierce Pharma
JANUARY 20, 2023
Martin Shkreli runs afoul of FTC for potentially skirting lifetime pharmaceutical industry ban fkansteiner Fri, 01/20/2023 - 15:34
Pharma Phorum
JANUARY 20, 2023
The FDA has delivered some good news to Astellas’ troubled gene therapy unit, lifting a clinical hold on its Pompe disease candidate AT845 and clearing the way for dosing of patients to resume.
Fierce Pharma
JANUARY 20, 2023
AbbVie jacks up Humira price by 8%, joining many other companies with January hikes: report kdunleavy Fri, 01/20/2023 - 10:06
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
Pharma Phorum
JANUARY 20, 2023
Design of Experiments (DOE) is a methodology misunderstood by many, understood by some, and actively used by even fewer than that.
Fierce Pharma
JANUARY 20, 2023
JPM23: Pfizer, Moderna and more look to combine COVID and flu vaccine markets zbecker Fri, 01/20/2023 - 14:48
Pharma Phorum
JANUARY 20, 2023
Leela Barham argues that the latest operational guidance for the NHS in England continues to illustrate a disconnect between the messages in big-ticket policy documents from the central government and the messages from the NHS in England on medicines.
Drug Patent Watch
JANUARY 20, 2023
Annual Drug Patent Expirations for CARNEXIV Carnexiv is a drug marketed by Lundbeck Pharms Llc and is included in one NDA. It is available from one supplier. There are six… The post New patent for Lundbeck Pharms drug CARNEXIV appeared first on DrugPatentWatch - Make Better Decisions. Patent Added
Pharmaceutical Commerce
JANUARY 20, 2023
North Carolina facility to manufacture Pfizer’s pipeline products us
Pharma Phorum
JANUARY 20, 2023
Eli Lilly has been unable to secure an accelerated FDA approval for its anti-amyloid Alzheimer’s disease therapy donanemab based on mid-stage clinical results, but says it remains on track to file a traditional submission around the middle of this year.
Drug Patent Watch
JANUARY 20, 2023
This chart shows the drugs with the most patents in Serbia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Serbia?
Pharma Phorum
JANUARY 20, 2023
For millions of people around the world living with infectious disease and cancer, the arrival of a new prophylactic or therapeutic vaccine on the market can be life changing. But in order for a treatment to reach patients, it needs to be launched.
Drug Channels
JANUARY 20, 2023
Today’s blog post comes from Andrew Duncan, Vice President of Business Operations and Analytics at PHIL. Andrew discusses how manufacturers can use data-driven strategy to understand utilization, increase patient access and adherence, and optimize gross-to-net.
Pharma Phorum
JANUARY 20, 2023
Hundreds of thousands of people in Great Britain have missed out on receiving medication that could protect them from serious cardiovascular disease (CVD) as a result of the COVID-19 pandemic, says a new study.
Pharma Phorum
JANUARY 20, 2023
The US Food and Drug Administration (FDA) has granted Seagen Inc.
Expert insights. Personalized for you.
264 
Let's personalize your content